Experiment 969710
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | INJECTION |
| Organism | Empty organism |
| Citation | MISER,JS: WILLIAM,AS: KRIVIT,W: HUGHES,CH: DAVIS,D: KRAILO,MD: HAMMOND,GD:. (1992). PHASE II TRIAL OF INDICINE N-OXIDE IN RELAPSED ACUTE LEUKEMIA OF CHILDHOOD.. 15(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | 31 CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA, 14 WITH ACUTE NON-LYMPHOBLASTIC LEUKEMIA IN RELAPSE AND 1 CHILD WITH CHRONIC MYELOGENOUS LEUKEMIA WERE TREATED IN THIS PHASE 11 STUDY. CHILDREN WERE GIVEN DOSES OF EITHER 2,000 MG/M2 LEUKEMIA ACHIEVED A PARTIAL RESPONSE LASTING 4 MONTHS. PATIENTS EXPERIENCED HEPATOTOXICITY RANGING FROM MILD, 63% TO SEVERE 9%. FOR 5 CONSECUTIVE DAYS WITH SUBSEQUENT COURSES ADMINISTERED EVERY 28 DAYS. 1 PATIENT WITH ACUTE LYMPHOBLASTIC LEUKEMIA ACHIEVED COMPLETE RESPONSE LASTING 6 MONTHS AND 1 MONTH RESPECTIVELY. THE PATIENT WITH CHRONIC MYELOGENOUS |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | . |
| Animal | HUMAN CHILD |
| Dose expression | DOSE |